Dr. Martens Management
Management criteria checks 4/4
Dr. Martens' CEO is Kenny Wilson, appointed in Jul 2018, has a tenure of 6.5 years. total yearly compensation is £788.00K, comprised of 93.3% salary and 6.7% bonuses, including company stock and options. directly owns 1.2% of the company’s shares, worth £8.54M. The average tenure of the management team and the board of directors is 3.2 years and 4 years respectively.
Key information
Kenny Wilson
Chief executive officer
UK£788.0k
Total compensation
| CEO salary percentage | 93.3% |
| CEO tenure | 6.5yrs |
| CEO ownership | 1.2% |
| Management average tenure | 3.2yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
Earnings Tell The Story For Dr. Martens plc (LON:DOCS) As Its Stock Soars 27%
Dec 06
Dr. Martens plc (LON:DOCS) Half-Yearly Results: Here's What Analysts Are Forecasting For This Year
Dec 01Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet
Sep 21Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?
Aug 20Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger
Jul 20There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings
Jun 19Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%
May 21The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Mar 27Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet
Mar 06Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 08Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market
Jan 21Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156
Jan 03Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156
Dec 13Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation
Oct 12Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Sep 13Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)
Jul 12A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Jun 02Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency
Feb 25Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?
Dec 17The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Oct 02Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively
Jul 04Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge
Jun 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | UK£29m |
| Jun 30 2024 | n/a | n/a | UK£49m |
| Mar 31 2024 | UK£788k | UK£735k | UK£69m |
| Dec 31 2023 | n/a | n/a | UK£86m |
| Sep 30 2023 | n/a | n/a | UK£103m |
| Jun 30 2023 | n/a | n/a | UK£116m |
| Mar 31 2023 | UK£773k | UK£721k | UK£129m |
| Dec 31 2022 | n/a | n/a | UK£153m |
| Sep 30 2022 | n/a | n/a | UK£177m |
| Jun 30 2022 | n/a | n/a | UK£179m |
| Mar 31 2022 | UK£2m | UK£700k | UK£181m |
| Dec 31 2021 | n/a | n/a | UK£118m |
| Sep 30 2021 | n/a | n/a | UK£54m |
| Jun 30 2021 | n/a | n/a | UK£44m |
| Mar 31 2021 | UK£815k | UK£118k | UK£35m |
Compensation vs Market: Kenny's total compensation ($USD979.26K) is below average for companies of similar size in the UK market ($USD1.46M).
Compensation vs Earnings: Kenny's compensation has been consistent with company performance over the past year.
CEO
Kenny Wilson (58 yo)
6.5yrs
Tenure
UK£788,000
Compensation
Mr. Kenneth Wilson, also known as Kenny, is Chief Executive Officer at Dr. Martens Limited and Dr. Martens plc since July 2018 and serves as its Director since January 5, 2021. He joined Dr. Martens Limite...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 6.5yrs | UK£788.00k | 1.2% £ 8.5m | |
| Chief Brand Officer | less than a year | UK£57.00k | no data | |
| CFO & Director | less than a year | no data | 0.017% £ 119.6k | |
| Chief Operating Officer | 6.6yrs | no data | no data | |
| Chief Technology Officer | no data | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| Chief Sustainability Officer | no data | no data | no data | |
| Chief Digital Officer | 6.8yrs | no data | no data | |
| President of APAC | 5.3yrs | no data | no data | |
| Chief Product Officer | 3.1yrs | no data | no data | |
| President of Americas | 3.2yrs | no data | no data | |
| President of EMEA | 1.7yrs | no data | no data |
3.2yrs
Average Tenure
54yo
Average Age
Experienced Management: DOCS's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 4yrs | UK£788.00k | 1.2% £ 8.5m | |
| CFO & Director | less than a year | no data | 0.017% £ 119.6k | |
| Independent Non-Executive Director | 1.7yrs | UK£62.00k | 0.0080% £ 56.7k | |
| Independent Non-Executive Director | 4yrs | UK£68.00k | 0.0021% £ 15.0k | |
| Independent Non-Executive Director | 4yrs | UK£96.00k | 0.010% £ 73.5k | |
| Representative Non-Independent Non-Executive Director | 4yrs | no data | no data | |
| Senior Independent Non-Executive Director | 4yrs | UK£101.00k | 0.0048% £ 34.1k | |
| Chair of the Board | 9.3yrs | UK£342.00k | 0.82% £ 5.8m |
4.0yrs
Average Tenure
54yo
Average Age
Experienced Board: DOCS's board of directors are considered experienced (4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 10:52 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dr. Martens plc is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Taylor | Barclays |
| David Roux | BofA Global Research |
| Louise Singlehurst | Goldman Sachs |